Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.41 USD | +0.51% | -3.21% | -17.01% |
04-22 | Citigroup Starts Coverage on Evolent Health With Buy Rating, $40 Price Target | MT |
03-28 | Canaccord Genuity Trims Price Target on Evolent Health to $44 From $45, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.01% | 3.14B | |
+4.63% | 32.55B | |
+18.40% | 7.66B | |
+20.94% | 3.85B | |
-22.16% | 1.35B | |
-31.01% | 1.18B | |
+4.40% | 934M | |
-34.81% | 911M | |
-25.64% | 840M | |
-15.01% | 726M |
- Stock Market
- Equities
- EVH Stock
- News Evolent Health, Inc.
- Insider Sell: Evolent Health